JGC
BIIB icon

J. Goldman & Co’s Biogen BIIB Stock Holding History

J. Goldman & Co’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4,600
Closed -$644K – 576
2025
Q3 		$644K Buy
+4,600
New +$622K 0.02% 367
2024
Q3 		– Sell
-40,000
Closed -$9.27M – 468
2024
Q2 		$9.27M Buy
40,000
+20,000
+100% +$4.35M 0.26% 119
2024
Q1 		$4.31M Buy
+20,000
New +$4.68M 0.14% 155
2023
Q2 		– Sell
-17,500
Closed -$4.87M – 384
2023
Q1 		$4.87M Sell
17,500
-77,500
-82% -$21.4M 0.2% 145
2022
Q4 		$26.3M Buy
95,000
+78,700
+483% +$22.2M 1.29% 15
2022
Q3 		$4.35M Buy
+16,300
New +$3.46M 0.21% 132
2021
Q1 		– Sell
-36,000
Closed -$8.81M – 437
2020
Q4 		$8.81M Buy
+36,000
New +$9.29M 0.45% 62

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return